Atlas Trials

A Phase II Clinical Study on the Efficacy and Safety of HRS-1780 in Participants With Primary Aldosteronism

Clinical trial NCT07470983 · RECRUITING

Trial details

NCT number
NCT07470983
Sponsor
Shandong Suncadia Medicine Co., Ltd.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Primary Aldosteronism
Start date
2026-04-23
Primary completion
2026-11-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.